ABBV
AbbVie
$80.06
1.09 (1.34%)
ABBV Stock Quote Delayed 15 Minutes
| Historical Data for ABBV |
|
|---|
| Date | Open | High | Low | Volume | Close | Change % |
|---|---|---|---|---|---|---|
| 05/24/19 | 81.09 | 81.10 | 79.87 | 3,872,900 | 80.06 | -1.09 -1.34% |
| 05/23/19 | 80.39 | 81.63 | 80.32 | 3,299,440 | 81.15 | -0.44 -0.54% |
| 05/22/19 | 80.51 | 81.75 | 79.88 | 4,218,654 | 81.59 | 0.71 0.88% |
| 05/21/19 | 80.33 | 81.50 | 80.32 | 4,841,857 | 80.88 | 1.06 1.33% |
| 05/20/19 | 79.02 | 80.39 | 78.91 | 4,395,310 | 79.82 | 0.36 0.45% |
| 05/17/19 | 78.53 | 80.08 | 78.02 | 4,756,800 | 79.46 | -0.04 -0.05% |
| 05/16/19 | 78.98 | 80.75 | 78.71 | 5,403,487 | 79.50 | 0.72 0.91% |
| 05/15/19 | 78.51 | 79.15 | 77.48 | 4,795,672 | 78.78 | 0.34 0.43% |
| 05/14/19 | 77.16 | 79.36 | 77.00 | 6,365,224 | 78.44 | 1.57 2.04% |
| 05/13/19 | 76.30 | 77.30 | 76.17 | 3,858,407 | 76.87 | -0.58 -0.75% |
| 05/10/19 | 77.45 | 77.73 | 75.62 | 4,731,800 | 77.45 | -0.46 -0.59% |
| 05/09/19 | 77.51 | 78.13 | 76.73 | 3,792,357 | 77.91 | -0.08 -0.10% |
| 05/08/19 | 77.95 | 78.89 | 77.32 | 3,820,744 | 77.99 | 0.04 0.05% |
| 05/07/19 | 78.60 | 78.99 | 77.17 | 4,275,326 | 77.95 | -1.31 -1.65% |
| 05/06/19 | 77.75 | 79.52 | 77.34 | 5,413,248 | 79.26 | 0.55 0.70% |
| 05/03/19 | 78.72 | 78.80 | 78.25 | 4,527,300 | 78.71 | 0.24 0.31% |
| 05/02/19 | 78.73 | 78.78 | 77.60 | 5,206,324 | 78.47 | -0.42 -0.53% |
| 05/01/19 | 79.60 | 79.68 | 78.61 | 5,231,892 | 78.89 | -0.50 -0.63% |
| 04/30/19 | 80.68 | 80.69 | 78.68 | 9,366,850 | 79.39 | -0.91 -1.13% |
| 04/29/19 | 80.46 | 80.98 | 79.91 | 6,443,960 | 80.30 | 0.60 0.75% |
| 04/26/19 | 79.67 | 80.65 | 79.40 | 5,789,900 | 79.70 | 0.36 0.45% |
| 04/25/19 | 80.05 | 80.47 | 76.91 | 10,442,754 | 79.34 | 0.67 0.85% |
| 04/24/19 | 79.23 | 79.59 | 78.44 | 7,053,134 | 78.67 | 0.01 0.01% |
| 04/23/19 | 78.15 | 79.66 | 77.75 | 9,920,075 | 78.66 | 0.51 0.65% |
| 04/22/19 | 77.60 | 79.10 | 77.50 | 5,358,368 | 78.15 | 0.58 0.75% |
| 04/18/19 | 78.06 | 78.21 | 76.81 | 7,785,200 | 77.57 | -0.41 -0.53% |
| 04/17/19 | 80.10 | 80.20 | 77.55 | 6,681,544 | 77.98 | -2.23 -2.78% |
| 04/16/19 | 81.11 | 81.30 | 80.01 | 3,624,740 | 80.21 | -0.82 -1.01% |
| 04/15/19 | 80.96 | 81.50 | 80.37 | 3,495,510 | 81.03 | 0.25 0.31% |
| 04/12/19 | 80.67 | 81.81 | 79.84 | 5,011,700 | 80.78 | -0.99 -1.21% |
| 04/11/19 | 83.20 | 83.25 | 81.23 | 9,092,702 | 81.77 | -1.18 -1.42% |
| 04/10/19 | 83.20 | 83.38 | 82.60 | 3,641,988 | 82.95 | 0.26 0.31% |
| 04/09/19 | 83.77 | 83.78 | 82.50 | 3,712,748 | 82.69 | -1.29 -1.54% |
| 04/08/19 | 83.70 | 84.00 | 82.78 | 3,499,247 | 83.98 | 0.53 0.64% |
| 04/05/19 | 82.82 | 84.18 | 82.67 | 3,996,600 | 83.45 | 0.64 0.77% |
| 04/04/19 | 83.04 | 83.38 | 82.07 | 4,827,927 | 82.81 | -0.27 -0.32% |
| 04/03/19 | 83.62 | 84.73 | 82.79 | 6,083,525 | 83.08 | 0.01 0.01% |
| 04/02/19 | 80.89 | 83.49 | 80.80 | 6,355,807 | 83.07 | 2.29 2.83% |
| 04/01/19 | 80.98 | 81.11 | 79.97 | 4,759,387 | 80.78 | 0.19 0.24% |
| 03/29/19 | 80.08 | 80.90 | 79.96 | 7,105,800 | 80.59 | 0.63 0.79% |
| 03/28/19 | 80.33 | 80.49 | 79.50 | 3,081,007 | 79.96 | 0.07 0.09% |
| 03/27/19 | 81.00 | 81.00 | 79.80 | 4,005,651 | 79.89 | -0.87 -1.08% |
| 03/26/19 | 79.85 | 81.19 | 79.80 | 4,921,921 | 80.76 | 1.25 1.57% |
| 03/25/19 | 79.50 | 80.04 | 78.41 | 4,007,860 | 79.51 | -0.25 -0.31% |
| 03/22/19 | 80.78 | 81.99 | 79.69 | 4,992,800 | 79.76 | -1.48 -1.82% |
| 03/21/19 | 79.88 | 81.31 | 79.26 | 5,159,100 | 81.24 | 0.81 1.01% |
| 03/20/19 | 80.72 | 80.90 | 80.06 | 5,360,886 | 80.43 | -0.39 -0.48% |
| 03/19/19 | 80.33 | 81.29 | 79.51 | 6,335,502 | 80.82 | 0.17 0.21% |
| 03/18/19 | 81.34 | 81.75 | 80.28 | 5,550,230 | 80.65 | -0.69 -0.85% |
| 03/15/19 | 80.06 | 81.46 | 79.11 | 12,751,200 | 81.34 | 1.39 1.74% |
| 03/14/19 | 79.00 | 80.40 | 78.41 | 6,161,716 | 79.95 | 1.02 1.29% |
| 03/13/19 | 78.92 | 79.30 | 78.15 | 5,984,713 | 78.93 | 0.19 0.24% |
| 03/12/19 | 78.48 | 79.14 | 78.05 | 6,128,895 | 78.74 | 0.66 0.85% |
| 03/11/19 | 77.57 | 78.31 | 77.27 | 8,078,355 | 78.08 | 0.50 0.64% |
| 03/08/19 | 77.67 | 78.04 | 77.09 | 6,189,100 | 77.58 | -0.66 -0.84% |
| 03/07/19 | 77.77 | 79.12 | 77.44 | 6,642,229 | 78.24 | 0.15 0.19% |
| 03/06/19 | 79.13 | 79.13 | 77.56 | 5,293,358 | 78.09 | -0.82 -1.04% |
| 03/05/19 | 79.38 | 79.90 | 78.72 | 5,899,940 | 78.91 | -0.55 -0.69% |
| Download Data To Spreadsheet | ||||||
ABBV Stock Predictions, Articles, and AbbVie News
Two Healthcare Stocks in the XLV Fund Stand Out
MRK stock and ABBV stock are promising healthcare stocks to invest in from the XLV fund. MRK is 6% of holdings and AbbVie makes up 3.5%.
Profit from Earnings Volatility With This Biotech Stocks Pairs Trade
Play a friendly and widening price spread in biotech stocks with a well-place purchase in Merck and an equally smart short in AbbVie.
3 Big Stock Charts for Friday: AbbVie, ConocoPhillips and MGM Resorts
The stock charts of COP, MGM and ABBV stock are moving into pivotal positions as the trading week winds down.
Is AbbVie Stock An Undiscovered Cannabis Play Waiting For Some Attention?
AbbVie stock's been fairly awful lately as its core drug is showing signs of slowing down. Yet ABBV stock should not be ignored since there’s a bit of a cannabis play here.
Does Recent Weakness in AbbVie Stock Make It a Buy? 3 Pros, 3 Cons
ABBV stock offers huge reward with its 5.3% dividend yield, and also huge risk with Humira's generic competition. What's the right play?
Why You Should Buy ABBV Stock for Income and Value
Although there could be further weakness in the AbbVie stock price in the coming months, ABBV stock belongs in a diversified portfolio.
ABBV Stock Is Worth a Look at Multi-Year Lows
The combination of valuation and yield makes ABBV stock a bargain following earnings that were only a slight disappointment.
AbbVie Earnings: ABBV Stock Falters on Q4 Miss
AbbVie earnings for the fourth quarter of 2018 saw ABBV stock falling today after reporting an earnings per share and revenue miss.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
